ATI RN
ATI Pharmacology Proctored Exam 2023 Questions
Question 1 of 5
A healthcare provider is reviewing the health care record of a client who reports urinary incontinence and asks about a prescription for Oxybutynin. The provider should recognize that Oxybutynin is contraindicated in the presence of which of the following conditions?
Correct Answer: D
Rationale: Oxybutynin is an anticholinergic medication that can increase intraocular pressure. It is contraindicated in clients with glaucoma, as it can worsen the condition. Glaucoma is a condition characterized by increased intraocular pressure, and using Oxybutynin can further elevate this pressure, potentially leading to serious complications such as vision impairment or damage to the optic nerve.
Question 2 of 5
A client has a new prescription for Prednisone. Which of the following laboratory values should be monitored by the healthcare provider?
Correct Answer: D
Rationale: When a client is prescribed Prednisone, monitoring serum glucose levels is essential. Prednisone, a corticosteroid, can lead to hyperglycemia. Therefore, regular monitoring of serum glucose helps in detecting and managing any potential hyperglycemic effects of the medication.
Question 3 of 5
A client has a new prescription for Prednisone. Which of the following laboratory values should the nurse monitor?
Correct Answer: D
Rationale: Prednisone is a corticosteroid that can cause hyperglycemia. The nurse should monitor the client's serum glucose levels closely to assess for elevated blood sugar levels.
Question 4 of 5
A nurse is teaching a client who has Graves' disease about her prescribed medications. Which of the following statements by the client indicates an understanding of the use of Propranolol in the treatment of Graves' disease?
Correct Answer: C
Rationale: Propranolol is a beta-adrenergic antagonist that decreases heart rate and controls tremors.
Question 5 of 5
A client is receiving treatment with capecitabine. Which of the following findings should the nurse monitor?
Correct Answer: C
Rationale: The nurse should monitor the client for neutropenia when receiving capecitabine, as it is a common adverse effect caused by bone marrow suppression. Neutropenia increases the risk of infection, making it essential for the nurse to closely monitor the client's white blood cell count and assess for signs of infection during treatment.
Similar Questions
Join Our Community Today!
Join Over 10,000+ nursing students using Nurselytic. Access Comprehensive study Guides curriculum for ATI-RN and 3000+ practice questions to help you pass your ATI-RN exam.
Subscribe for Unlimited Access